EP 3256471 B1 20181212 - NOVEL 2-OXO-6,7-DIHYDROBENZO[A]QUINOLIZINE-3-CARBOXYLIC ACID DERIVATIVES FOR THE TREATMENT AND PROPHYLAXIS OF HEPATITIS B VIRUS INFECTION
Title (en)
NOVEL 2-OXO-6,7-DIHYDROBENZO[A]QUINOLIZINE-3-CARBOXYLIC ACID DERIVATIVES FOR THE TREATMENT AND PROPHYLAXIS OF HEPATITIS B VIRUS INFECTION
Title (de)
NEUARTIGE 2-OXO-6,7-DIHYDROBENZO[A]CHINOLIZIN-3-CARBOXYLSÄURE-DERIVATE ZUR BEHANDLUNG UND PROPHYLAXE VON HEPATITIS-B-VIRUSINFEKTION
Title (fr)
NOUVEAUX DÉRIVÉS D'ACIDE CARBOXYLIQUE 2-OXO-6,7-DIHYDROBENZO[A]QUINOLIZINE-3 POUR LE TRAITEMENT ET LA PROPHYLAXIE D'UNE INFECTION PAR LE VIRUS DE L'HÉPATITE B
Publication
Application
Priority
- CN 2015072741 W 20150211
- EP 2016052585 W 20160208
Abstract (en)
[origin: WO2016128335A1] The invention provides novel compounds having the general formula (I), wherein R1, R2, R3, R4, R5 and Ar are as described herein, compositions including compounds and methods of using the compounds.
IPC 8 full level
C07D 471/04 (2006.01); A61K 31/4375 (2006.01); A61P 31/12 (2006.01)
CPC (source: CN EP US)
A61P 1/16 (2017.12 - EP); A61P 31/12 (2017.12 - EP); A61P 31/20 (2017.12 - EP); C07D 471/04 (2013.01 - CN EP US)
Designated contracting state (EPC)
AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR
DOCDB simple family (publication)
WO 2016128335 A1 20160818; CN 107207505 A 20170926; CN 107207505 B 20181214; EP 3256471 A1 20171220; EP 3256471 B1 20181212; HK 1244281 B 20200207; JP 2018505198 A 20180222; JP 6435054 B2 20181205; US 10093671 B2 20181009; US 2017342069 A1 20171130
DOCDB simple family (application)
EP 2016052585 W 20160208; CN 201680008772 A 20160208; EP 16703311 A 20160208; HK 18103815 A 20180319; JP 2017542045 A 20160208; US 201715674810 A 20170811